DARPA Biological Technologies Office
Supports biology-inspired defense innovation in the United States by funding projects that turn biology into mission capability.
DARPA's Biological Technologies Office sits inside the Defense Advanced Research Projects Agency at the point where biology meets defense need. It funds synthetic biology, biomanufacturing, biomaterials, biothreat detection and response, human performance, and neurotechnology for work that can change how the US protects warfighters. Its office-wide BAA is the main route into the office, and awards run from USD 1 million to USD 30 million with a median actual award of USD 8 million. The intake pattern is rolling, US-based for-profit and nonprofit teams are eligible, individuals are not, and the usual work window is multi-year with TRL 2 to 6 fit. BTO places biosafety and biosecurity review at the center of selection, and the notes point to cooperative agreements, other transaction awards, or procurement contracts depending on the program. The current vehicle is HR001126S0003, and some efforts carry restricted publication terms or classified extensions, so applicants need a strong compliance posture as well as a clear technical path.
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.